Key takeaways for me were:
- Confirmation that CRO is "extremely well financed"
- AF re-affirming CR
- Phase 1 testing completed and some issues were discovered and challenges needed to be met BUT they have already moved into Phase 2. I take that to mean either: A) Issues/Challenges were minimal or B) Response to fix them was quick and either or both of these would be great.
- AF mentions taking a more aggressive approach with how they commercialise. I take this to mean an acceleration of commercialisation strategy.
All in all, a great interview showcasing that this money will be well spent and growth to increase
Key takeaways for me were:Confirmation that CRO is "extremely...
-
- There are more pages in this discussion • 355 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $30.27M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $96.01K | 12.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 7759126 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 3223458 | 8 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| SPX (ASX) Chart |